000 02295nam a22003015i 4500
001 402655
003 ES-MaUEC
005 20240528105918.0
007 cr nn 008mamaa
008 230921s2023 si | o |||| 0|eng d
020 _a9789819958269
024 7 _a10.1007/978-981-99-5826-9
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aR856-857
_b2023 EB
245 0 0 _aPharmacological Interventions for Osteoporosis
_cedited by Andy H Choi, Sian Yik Lim
250 _a1st ed. 2023
264 1 _aSingapore
_bSpringer International Publishing
_c2023
300 _a1 recurso en línea
336 _atexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
490 0 _aTissue Repair and Reconstruction
_x2731-9199
505 0 _aBisphosphonates and Osteonecrosis of the jaw -- Denosumab: Clinical Applications and Outcomes -- Romosozumab: Clinical Outcomes and Outcomes -- Abaloparatide: Clinical Outcomes and its Effects in Bone Regeneration -- Teriparatide: Clinical Outcomes and its Effects in Bone Regeneration.
520 _aThis book provides readers a fundamental insight into the basic properties of the pharmaceutical agents used in the treatment of osteoporosis. It provides insight into mechanisms of action, updated information on clinical utility, and possible side effects associated with the use of these pharmaceutical agents. In particular, it highlights the use of two monoclonal antibodies romosozumab and denosumab in activating osteoblast differentiation and inhibiting osteoclasts. It also discusses two anabolic pharmaceutical agents, teriparatide and abaloparatide to treat osteoporosis. They have been shown to reduce the incidence of non-vertebral and vertebral fractures significantly after they were administered to patients daily as subcutaneous injections. The content of this book caters to researchers, scientists, and clinical practitioners who are interested in the treatment of osteoporosis using pharmaceutical agents.
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-99-5826-9
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
988 _aSpringer_Medicine_2023
999 _c402655
_d402655